n-methylaspartate has been researched along with Nervous System Disorders in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.33) | 18.7374 |
| 1990's | 23 (63.89) | 18.2507 |
| 2000's | 7 (19.44) | 29.6817 |
| 2010's | 3 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Z; Girling, K; Lee, W; Lin, SZ; Shyu, WC; Taghibiglou, C; Wang, YT; Zhang, S | 1 |
| Ahmad, AS; Doré, S; Maruyama, T; Narumiya, S; Saleem, S | 1 |
| Danesh-Meyer, HV; Levin, LA | 1 |
| Benarroch, EE | 1 |
| Blanc, T; Dahmani, S; Jegou-Colleter, S; Laudenbach, V; Marret, S; Tourrel, F | 1 |
| Cepeda, C; Levine, MS | 1 |
| Aguera, M; Honnorat, J; Laute, MA; Manto, MU; Pandolfo, M; Rogemond, V | 1 |
| Anthony, DC; Blamire, AM; Lowe, JP; Martin, MJ; Obrenovitch, TP; Sibson, NR | 1 |
| Koyama, T; Muraki, A; Ohmori, T; Yamashita, I | 1 |
| Beal, MF; Finklestein, S; Henshaw, R; Kirschner, PB; Schulz, JB; Trubetskoy, V; Weise, J | 1 |
| Danysz, W; Mobley, SL; Wenk, GL | 2 |
| Desagher, S; Glowinski, J; Marin, P; Maus, M; Prémont, J | 1 |
| Olney, JW | 1 |
| Birch, PJ; Elliott, PJ; Harrison, SM; Smith, GD; Wiseman, J | 1 |
| Hara, H; Shimazawa, M; Sukamoto, T; Yokota, K | 1 |
| Fisher, M; Jonas, S; Jones S [corrected to Jonas, S]; Sacco, RL | 1 |
| Beal, MF; Finklestein, SP; Nozaki, K | 1 |
| Dawson, TM; Dawson, VL | 1 |
| Ikonomidou, C; Turski, L | 1 |
| Brace, H; Latimer, M; Winn, P | 1 |
| Aizenman, E; Brimecombe, JC; Potthoff, WK; Rosenberg, PA | 1 |
| Mishina, M; Miyamoto, Y; Mori, H; Nabeshima, T; Noda, Y; Yamada, K | 1 |
| Bains, JS; Shaw, CA | 1 |
| Benavides, J; Fage, D; Toulmond, S; Vige, X | 1 |
| Chuang, DM; Gao, XM | 1 |
| Lazzaro, A; Lipartiti, M; Manev, H | 1 |
| Choi, DW; Weiss, JH | 1 |
| Kollegger, H; McBean, GJ; Tipton, KF | 1 |
| DeLaPaz, R; Kunis, D; Saleh, J; Steinberg, GK | 1 |
| Mohri, T; Suzuki, R; Takadera, T | 1 |
| Berger, SP; Markwell, MA; Paul, SM | 1 |
| Halsey, MJ; Meldrum, BS; Millan, MH; Wardley-Smith, B | 1 |
| Meldrum, B | 1 |
| Choi, DW; Goldberg, MP; Kim, JP | 1 |
10 review(s) available for n-methylaspartate and Nervous System Disorders
| Article | Year |
|---|---|
Neuroprotection: extrapolating from neurologic diseases to the eye.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Endpoint Determination; Excitatory Amino Acid Antagonists; Glaucoma, Open-Angle; Humans; Memantine; N-Methylaspartate; Nervous System Diseases; Neuroprotective Agents; Optic Nerve Diseases; Riluzole | 2009 |
NMDA receptors: recent insights and clinical correlations.
Topics: Animals; Calcium; Cell Survival; Central Nervous System; Glutamic Acid; Humans; Ion Channel Gating; Ion Channels; N-Methylaspartate; Nerve Net; Nervous System Diseases; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate | 2011 |
[Neurological consequences after long-term sedation in the ICU].
Topics: Aging; Anesthetics, General; Animals; Cesarean Section; Conscious Sedation; Critical Care; Excitatory Amino Acid Agonists; Female; Fetal Alcohol Spectrum Disorders; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Infant, Newborn; Infant, Premature; Intensive Care Units; N-Methylaspartate; Nervous System Diseases; Neurotoxicity Syndromes; Pregnancy; Primates; Synaptic Transmission; Teratogens | 2012 |
Where do you think you are going? The NMDA-D1 receptor trap.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Calcium; Corpus Striatum; Diffusion; Dopamine; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Models, Neurological; N-Methylaspartate; Nervous System Diseases; Neurons; Organ Culture Techniques; Protein Interaction Mapping; Protein Subunits; Protein Transport; Rats; Receptors, Dopamine D1; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synaptic Membranes | 2006 |
New mechanisms of excitatory transmitter neurotoxicity.
Topics: Acetylcholine; Animals; Glutamic Acid; Humans; N-Methylaspartate; Nervous System Diseases; Neurotoxins; Receptors, Amino Acid; Receptors, Metabotropic Glutamate; Syndrome | 1994 |
Prophylactic neuroprotection for cerebral ischemia.
Topics: Cerebrovascular Disorders; Coronary Artery Bypass; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; N-Methylaspartate; Nervous System Diseases; Nimodipine; Randomized Controlled Trials as Topic | 1994 |
Nitric oxide in neuronal degeneration.
Topics: Animals; Humans; N-Methylaspartate; Nerve Degeneration; Nervous System; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase | 1996 |
Neurodegenerative disorders: clues from glutamate and energy metabolism.
Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Damage, Chronic; Brain Injuries; Brain Ischemia; Energy Metabolism; Excitatory Amino Acid Antagonists; Glutamates; Humans; N-Methylaspartate; Nerve Degeneration; Nervous System Diseases; Neurotoxins | 1996 |
Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial?
Topics: Alkylation; Animals; Binding Sites; Biomarkers; Humans; N-Methylaspartate; Nervous System Diseases; Nitric Oxide; Oxidation-Reduction; Receptors, N-Methyl-D-Aspartate | 1998 |
Differential vulnerability to excitatory amino acid-induced toxicity and selective neuronal loss in neurodegenerative diseases.
Topics: Amino Acids; Animals; Humans; N-Methylaspartate; Nervous System Diseases; Neurons; Neurotoxins; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1991 |
26 other study(ies) available for n-methylaspartate and Nervous System Disorders
| Article | Year |
|---|---|
Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries.
Topics: Animals; Brain; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Agonists; Female; Fluorodeoxyglucose F18; Green Fluorescent Proteins; L-Lactate Dehydrogenase; Male; Mice; Mutation; N-Methylaspartate; Nervous System Diseases; Neurons; Nuclear Localization Signals; Peptides; Pregnancy; Protein Transport; PTEN Phosphohydrolase; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2013 |
PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Brain Infarction; Brain Injuries; Brain Ischemia; Disease Models, Animal; Excitatory Amino Acid Agonists; Latanoprost; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Nervous System Diseases; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Receptors, Prostaglandin E | 2009 |
Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Topics: Animals; Autoantibodies; Cerebellum; Chromatography, Affinity; Drug Administration Routes; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Agonists; Glutamate Decarboxylase; Glutamic Acid; Humans; Immunoglobulin G; Male; Microdialysis; Muscle, Skeletal; N-Methylaspartate; Nervous System Diseases; Nitric Oxide; Rats; Sciatic Nerve; Spinal Cord | 2007 |
Acute astrocyte activation in brain detected by MRI: new insights into T(1) hypointensity.
Topics: Animals; Astrocytes; Brain Ischemia; Endothelin-1; Magnetic Resonance Imaging; N-Methylaspartate; Nervous System Diseases | 2008 |
Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dizocilpine Maleate; Dopamine; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methylaspartate; Nervous System Diseases; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin | 1993 |
Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Cell Death; Excitatory Amino Acids; Fibroblast Growth Factor 2; Hypoxia; Male; Malonates; N-Methylaspartate; Nervous System Diseases; Neurons; Rats; Rats, Sprague-Dawley | 1995 |
Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat.
Topics: Acetylcholine; Animals; Basal Ganglia; Behavior, Animal; Cerebral Cortex; Choline O-Acetyltransferase; Male; Memantine; Memory Disorders; N-Methylaspartate; Nervous System Diseases; Quisqualic Acid; Rats; Receptors, N-Methyl-D-Aspartate; Space Perception | 1994 |
Nicotine: a new neuroprotective agent?
Topics: Animals; Cholinergic Agents; Humans; N-Methylaspartate; Nervous System Diseases; Nicotine; Receptors, N-Methyl-D-Aspartate | 1994 |
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity.
Topics: Acetylcholine; Animals; Carbachol; Cells, Cultured; Dimethylphenylpiperazinium Iodide; Hexamethonium; Mice; N-Methylaspartate; Neostriatum; Nerve Degeneration; Nervous System Diseases; Neurons; Nicotine; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 1994 |
Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation.
Topics: Animals; Chronic Disease; Dizocilpine Maleate; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; N-Methylaspartate; Nervous System Diseases; Nociceptors; Physical Stimulation; Rats; Receptors, N-Methyl-D-Aspartate; Sciatic Nerve | 1994 |
Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Chelating Agents; Female; Glutamates; Glutamic Acid; Hippocampus; N-Methylaspartate; Nervous System Diseases; Piperazines; Pregnancy; Rats; Rats, Wistar | 1993 |
Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats.
Topics: Animals; Animals, Newborn; Corpus Striatum; Female; Fibroblast Growth Factor 2; Injections; Injections, Intraperitoneal; N-Methylaspartate; Nervous System Diseases; Pregnancy; Rats; Rats, Sprague-Dawley | 1993 |
MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis.
Topics: Amantadine; Animals; Basal Ganglia; Cerebral Cortex; Choline O-Acetyltransferase; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Memantine; N-Methylaspartate; Nervous System Diseases; Neuroprotective Agents; Rats; Receptors, N-Methyl-D-Aspartate | 1995 |
Neurotoxicity, blood-brain barrier breakdown, demyelination and remyelination associated with NMDA-induced lesions of the rat lateral hypothalamus.
Topics: Animals; Blood-Brain Barrier; Buffers; Demyelinating Diseases; Excitatory Amino Acid Agonists; Hypothalamic Area, Lateral; Immunohistochemistry; Male; Microinjections; Myelin Sheath; N-Methylaspartate; Nervous System Diseases; Neurons; Rats | 1997 |
Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Calcium; Corpus Striatum; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Frontal Lobe; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Learning; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Motor Activity; N-Methylaspartate; Nervous System Diseases; Neurons; Protein Subunits; Receptors, N-Methyl-D-Aspartate; Serotonin; Thalamus | 2001 |
Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease.
Topics: Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Flour; Glutamic Acid; Glutathione; Kynurenic Acid; L-Lactate Dehydrogenase; Male; Methionine Sulfoximine; Mice; Mice, Inbred Strains; N-Methylaspartate; Nervous System Diseases; Oxidative Stress; Plants, Toxic; Rats; Rats, Sprague-Dawley; Sitosterols | 2002 |
Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons.
Topics: Animals; Cells, Cultured; Cerebellum; Choline O-Acetyltransferase; Corpus Striatum; Cyclic AMP; Glutamate Decarboxylase; Interleukin-6; Male; N-Methylaspartate; Nervous System Diseases; Neurons; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques | 1992 |
Carbamazepine-induced neurotoxicity and its prevention by NMDA in cultured cerebellar granule cells.
Topics: 2-Amino-5-phosphonovalerate; Animals; Binding, Competitive; Carbamazepine; Cells, Cultured; Cerebellum; Cytoplasmic Granules; N-Methylaspartate; N-Methylscopolamine; Nervous System Diseases; Ouabain; Parasympatholytics; Rats; Rats, Inbred Strains; Scopolamine Derivatives; Sodium-Potassium-Exchanging ATPase | 1992 |
Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain.
Topics: Animals; Animals, Newborn; G(M1) Ganglioside; Injections, Intraventricular; N-Methylaspartate; Nervous System Diseases; Organ Size; Rats; Sphingosine | 1992 |
The inhibition of glutamine synthetase in rat corpus striatum in vitro by methionine sulfoximine increases the neurotoxic effects of kainate and N-methyl-D-aspartate.
Topics: Animals; Cerebellum; Corpus Striatum; Drug Synergism; Female; Glutamate-Ammonia Ligase; Kainic Acid; Methionine Sulfoximine; N-Methylaspartate; Nerve Degeneration; Nervous System Diseases; Neuroglia; Phosphopyruvate Hydratase; Rats; Rats, Inbred Strains | 1991 |
Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
Topics: Animals; Brain; Dextrorphan; Dose-Response Relationship, Drug; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; N-Methylaspartate; Nervous System Diseases; Rabbits | 1991 |
Protection by ethanol of cortical neurons from N-methyl-D-aspartate-induced neurotoxicity is associated with blocking calcium influx.
Topics: 2-Amino-5-phosphonovalerate; Animals; Calcium; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cerebral Cortex; Ethanol; Female; Ketamine; L-Lactate Dehydrogenase; N-Methylaspartate; Nervous System Diseases; Neurons; Pregnancy; Rats | 1990 |
The polyamine synthesis inhibitor alpha-difluoromethylornithine blocks NMDA-induced neurotoxicity.
Topics: Animals; Biogenic Polyamines; Cells, Cultured; Eflornithine; Female; Mice; Mice, Inbred C57BL; N-Methylaspartate; Nervous System Diseases; Neurons; Phencyclidine; Pregnancy; Rats | 1990 |
Studies on the role of the NMDA receptor in the substantia nigra pars reticulata and entopeduncular nucleus in the development of the high pressure neurological syndrome in rats.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Atmospheric Pressure; Catalepsy; Globus Pallidus; Male; N-Methylaspartate; Nervous System Diseases; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Seizures; Substantia Nigra; Syndrome | 1989 |
Excitatory amino acid antagonists as novel anticonvulsants.
Topics: Amino Acids, Dicarboxylic; Animals; Anticonvulsants; Aspartic Acid; Epilepsy; Glutamates; Kainic Acid; N-Methylaspartate; Nerve Degeneration; Nervous System Diseases; Oxadiazoles; Quisqualic Acid; Receptors, Amino Acid; Receptors, Cell Surface; Structure-Activity Relationship | 1986 |
High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity.
Topics: Animals; Aspartic Acid; Cells, Cultured; Cerebral Cortex; Female; L-Lactate Dehydrogenase; Mice; N-Methylaspartate; Naloxone; Nervous System Diseases; Oxadiazoles; Pregnancy; Quisqualic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1987 |